Keith Goldan
Chief Financial Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | $516,900 | $2,470,802 |
| 2024 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | $497,000 | $2,824,133 |
| 2023 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | $470,300 | $2,826,034 |
| 2022 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | $249,900 | $2,992,538 |
Earnings-call appearances
-
Syndax Pharmaceuticals Inc Q2 FY2026 Earnings Call2026-08-04
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q3 FY2025 Earnings Call2025-11-03
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q2 FY2025 Earnings Call2025-08-04
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q1 FY2025 Earnings Call2025-05-05
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q4 FY2024 Earnings Call2025-03-03
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q3 FY2024 Earnings Call2024-11-05
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q2 FY2024 Earnings Call2024-08-01
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q1 FY2024 Earnings Call2024-05-08
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q4 FY2023 Earnings Call2024-02-27
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q3 FY2023 Earnings Call2023-11-02
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q2 FY2023 Earnings Call2023-08-03
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q1 FY2023 Earnings Call2023-05-08
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q4 FY2022 Earnings Call2023-02-28
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q3 FY2022 Earnings Call2022-11-03
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q2 FY2022 Earnings Call2022-08-08
Syndax Pharmaceuticals Inc (SNDX)
-
Option Therapeutics Inc. Q1 FY2022 Earnings Call2021-09-30
Option Therapeutics Inc. (OPTN)
-
Option Therapeutics Inc. Q3 FY2021 Earnings Call2021-03-31
Option Therapeutics Inc. (OPTN)
-
Option Therapeutics Inc. Q2 FY2021 Earnings Call2020-12-31
Option Therapeutics Inc. (OPTN)
-
Option Therapeutics Inc. Q4 FY2020 Earnings Call2020-06-30
Option Therapeutics Inc. (OPTN)
-
Option Therapeutics Inc. Q1 FY2020 Earnings Call2019-09-30
Option Therapeutics Inc. (OPTN)